戻る Agenda
Driving Enrollment with a Patient-Centric Focus to Artificial Intelligence
Session Chair(s)
Rob Wynden, PHD
Chief Executive Officer
Aloha Health Network, United States
Artificial intelligence, blockchain, natural language processing and real world evidence have been all the rage lately in industry news. Hear perspectives on these new technologies from a panel of experts from sponsor, technology vendor, patient advocacy group, and patients on what's working and what's not.
Learning Objective : Describe how to drive patient enrollment in clinical studies with a patient-centric approach, allowing patients to pre-screen themselves and retargeting them if excluded; Identify how to address patient recruitment issues associated with pre-screening, screening and dropout to reduce the current average conversion ratio from 10:1; Discuss how to reduce pre-screening burden via mining of EMR records.
Speaker(s)
Introduction to Patient-Facing Trial Technology
Rob Wynden, PHD
Aloha Health Network, United States
Chief Executive Officer
A Bulls-Eye Clinical Trial via Patient's Point- of-View
Abhit Singh, MD, MHA
WeHeal Foundation, United States
Chief Medical Advisor, Medical Advisory Board
User-Driven Markets Data that Help Clinicians Assess Treatments and Cure Diseases
Collin Powell, MBA
The Health Exchange Market (THEM), United States
Founder, Chief Executive Officer
Turning Clinical Trial Recruitment on its Head Using EHR-Connected Applicants
Scott Cressman
Sharecare, United States
Director of Product
Pragmatism and AI in Research
Mike Nolte, MBA
Signant Health, United States
Chief Executive Officer